A beta-1 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery.
Indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures.
University Medical Center, Ulm University, Ulm, Baden-Württemberg, Germany
John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom
Department of Anaesthesia & Intensive Care, Århus University Hospital, Århus, Denmark
UW - Madison, Madison, Wisconsin, United States
Hospital Clinico Universidad Catolica de Chile, Santiago, RM, Chile
Departement of Anesthesiology and Intensive Care of the University of Rome "La Sapienza" Viale del Policlinico 155, Rome, Italy
WAKE FOREST UNIVERSITY Baptist Medical Center, Winston-Salem, North Carolina, United States
Legacy Good Samaritan, Portland, Oregon, United States
Oregon Health and Science University, Portland, Oregon, United States
Kaiser Permanente Sunnyside, Clackamas, Oregon, United States
Herzzentrum Leipzig, Klinik für Kinderkardiologie, Leipzig, Saxony, Germany
Herz-und Diabeteszentrum Nordrhein-Westfalen, Bad Oeynhausen, North Rhine-Westphalia, Germany
Deutsches Kinderherzzentrum St. Augustin, Sankt Augustin, North Rhine-Westphalia, Germany
Onze Lieve Vrouwe Gasthuis, intensive care, Amsterdam, Netherlands
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.